Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 6, 2010, Pages 863-867

  Han, Mingyong ^a   Liu, Qi ^a   Yu, Jiekai ^b   Zheng, Shu ^b  

^a SHANDONG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chemotherapy; Non small cell lung cancer; Proteomics; SELDI TOF MS

Indexed keywords

CISPLATIN; DOCETAXEL; MOLECULAR MARKER;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CLINICAL ARTICLE; HUMAN; LUNG NON SMALL CELL CANCER; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TREATMENT RESPONSE;

CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAXOIDS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953216536     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.169     Document Type: Article

References (23)

1. Manegold C, Thatcher N. Survival improvement in thoracic cancer: progress from the last decade and beyond. Lung Cancer 2007;57:S3-5.
2. Puglisi F, Andreetta C, Fasola G. Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006. Expert Opin Pharmacother 2006;7: 2309-2318
3. Strauss LT, Herndon J, Chang J, Parker WY, Levy DA, Bowens SB, et al. Abortion surveillance-United States, 2001. MMWR Surveill Summ 2004;53:1-32.
4. Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH. Clinical model to predict survival chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group data. J Clin Oncol 2005;23:175-183
5. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
6. Engwegen JY, Gast MC, Schellens JH, Beijnen JH. Clinical proteomics: searching for better tumour markers with SELDITOF mass spectrometry. Trends Pharmacol Sci 2006;27:251-259
7. Mosley K, Tam FW, Edwards RJ, Crozier J, Pusey CD, Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 2006;45:1497-1504
8. Tomosugi N, Kitagama K, Takahashi N, Sugai S, Ishikawa I. Diagnostic potential of tear proteome patterns in Sjögren's syndrome. J Proteome Res 2005;4:820-825
9. Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, et al. Prediction of pancreatic cancer by serum biomarkers using surface- enhanced laser desorption/ionization-based decision tree classification. Oncology 2005;68:79-86.
10. Koopmann J, Zhang Z, White N, Rosenzweig J, Fedarko N, Jagannath S, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin Cancer Res 2004;10:860-868
11. Merchant M, Weinberger SR. Recent advancements in surfaceenhanced laser desorption/ionization, time-of-flight, mass spectrometry. Electrophoresis 2000;21:1164-1177
12. World Health Organization. WHO handbook for reporting results of cancer treatment. Geneva, Switzerland: World Health Organization, 1979; WHO Offset Publication No. 48.
13. Japan Lung Cancer Society. Classification of lung cancer, 1st ed. Tokyo, Japan: Kanehara & Co., Ltd., 2000:49-52.
14. Liu Y. Active learning with support vector machine applied to gene expression data for cancer classification. J Chem Inf Comput Sci 2004;44:1936-1941
15. Lin HH, Han LY, Cai CZ, Ji ZL, Chen YZ. Prediction of transporter family from protein sequence by support vector machine approach. Proteins 2006;62:218-231
16. Pujol JL, Quantin X, Jacot W, Serre A, Fayolle V. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer. Lung Cancer 2003;39:131-138
17. Liu Y, Sturgis CD, Grzybicki DM, Jasnosz KM, Olson PR, Tong M, et al. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Mod Pathol 2001;14:880-885
18. Petricoin EF, Liotta LA. SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. Curr Opin Biotechnol 2004;15:24-30.
19. Somorjai RL, Dolenko B, Baumgartner R. Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 2003; 19:1484-1491
20. Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, Haussler D. Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics 2000;16:906-914
21. Byvatov E, Schneider G. Support vector machine applications in bioinformatics. Appl Bioinformatics 2003;2:67-77.
22. Jorissen RN, Gilson MK. Virtual screening of molecular databases using a support vector machine. J Chem Inf Model 2005; 45:549-561
23. Wiesner A. Detection of tumor markers with ProteinChip technology. Curr Pharm Biotechnol 2004;5:45-67.